Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Fujii, Tsutomu ^a   Fuchs, Bryan C ^a   Yamada, Suguru ^a   Lauwers, Gregory Y ^a   Kulu, Yakup ^a   Goodwin, Jonathan M ^a   Lanuti, Michael ^a   Tanabe, Kenneth K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CARBON TETRACHLORIDE; CD133 ANTIGEN; DESMIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; LIVER FIBROSIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL; UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOWN REGULATION; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, CD; CARBON TETRACHLORIDE; CELL DIFFERENTIATION; DESMIN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEINS; HEPATIC STELLATE CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED STRAINS; PEPTIDES; RECEPTOR, EPIDERMAL GROWTH FACTOR; UP-REGULATION;

EID: 77954324574     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-79     Document Type: Article

References (42)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-76. 10.1053/j.gastro.2007.04.061, 17570226.
2. Simonetti RG, Camma C, Fiorello F, Politi F, D'Amico G, Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991, 36:962-72. 10.1007/BF01297149, 1649041.
3. Pierce RA, Glaug MR, Greco RS, Mackenzie JW, Boyd CD, Deak SB. Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rats. J Biol Chem 1987, 262:1652-8.
4. Perez Tamayo R. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis?. Hepatology 1983, 3:112-20. 10.1002/hep.1840030118, 6337081.
5. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol 1998, 153:515-25. 1852991, 9708811.
6. Manibusan MK, Odin M, Eastmond DA. Postulated carbon tetrachloride mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2007, 25:185-209.
7. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000, 275:2247-50. 10.1074/jbc.275.4.2247, 10644669.
8. Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000, 35:665-72. 10.1007/s005350070045, 11023037.
9. Kordes C, Sawitza I, Muller-Marbach A, Ale-Agha N, Keitel V, Klonowski-Stumpe H, Haussinger D. CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun 2007, 352:410-7. 10.1016/j.bbrc.2006.11.029, 17118341.
10. Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA 2007, 104:17081-6. 10.1073/pnas.0704126104, 2040457, 17940036.
11. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. Jama 2008, 299:53-60. 10.1001/jama.2007.65, 18167406.
12. Komuves LG, Feren A, Jones AL, Fodor E. Expression of epidermal growth factor and its receptor in cirrhotic liver disease. J Histochem Cytochem 2000, 48:821-30.
13. Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 2009, 315:683-96. 10.1016/j.yexcr.2008.07.029, 19278030.
14. Lai WH, Cameron PH, Wada I, Doherty JJ, Kay DG, Posner BI, Bergeron JJ. Ligand-mediated internalization, recycling, and downregulation of the epidermal growth factor receptor in vivo. J Cell Biol 109:2741-9. 10.1083/jcb.109.6.2741, 2115960, 2592403.
15. Mead JE, Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 1989, 86:1558-62. 10.1073/pnas.86.5.1558, 286737, 2922399.
16. Yokoi Y, Namihisa T, Kuroda H, Komatsu I, Miyazaki A, Watanabe S, Usui K. Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 1984, 4:709-14. 10.1002/hep.1840040425, 6204917.
17. Zalatnai A, Lapis K. Simultaneous induction of liver cirrhosis and hepatocellular carcinomas in F-344 rats: establishment of a short hepatocarcinogenesis model. Exp Toxicol Pathol 1994, 46:215-22.
18. Ferencz V, Horvath C, Kari B, Gaal J, Meszaros S, Wolf Z, Hegedus D, Horvath A, Folhoffer A, Szalay F. Bone disorders in experimentally induced liver disease in growing rats. World J Gastroenterol 2005, 11:7169-73.
19. Edwards JE, Dalton AJ. Induction of cirrhosis of the liver and of hepatomas in mice with carbon tetrachloride. J Natl Cancer Inst 1942, 3:19-41.
20. Stowell RE, Lee CS, Tsuboi KK, Villasana A. Histochemical and microchemical changes in experimental cirrhosis and hepatoma formation in mice by carbon tetrachloride. Cancer Res 1951, 11:345-54.
21. Belyaev ND, Budker VG, Deriy LV, Smolenskaya IA, Subbotin VM. Liver plasma membrane-associated fibroblast growth: stimulatory and inhibitory activities during experimental cirrhosis. Hepatology 1992, 15:525-31. 10.1002/hep.1840150327, 1544635.
22. Terai S, Sakaida I, Yamamoto N, Omori K, Watanabe T, Ohata S, Katada T, Miyamoto K, Shinoda K, Nishina H, Okita K. An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem 2003, 134:551-8. 10.1093/jb/mvg173, 14607982.
23. Xue F, Takahara T, Yata Y, Kuwabara Y, Shinno E, Nonome K, Minemura M, Takahara S, Li X, Yamato E, Watanabe A. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 2003, 52:694-700. 10.1136/gut.52.5.694, 1773642, 12692055.
24. Black D, Bird MA, Samson CM, Lyman S, Lange PA, Schrum LW, Qian T, Lemasters JJ, Brenner DA, Rippe RA, Behrns KE. Primary cirrhotic hepatocytes resist TGFbeta-induced apoptosis through a ROS-dependent mechanism. J Hepatol 2004, 40:942-51. 10.1016/S0168-8278(04)00128-X, 15158334.
25. Ozdogan M, Ersoy E, Dundar K, Albayrak L, Devay S, Gundogdu H. Beneficial effect of hyperbaric oxygenation on liver regeneration in cirrhosis. J Surg Res 2005, 129:260-4. 10.1016/j.jss.2005.06.036, 16140330.
26. Kim KH, Kim HC, Hwang MY, Oh HK, Lee TS, Chang YC, Song HJ, Won NH, Park KK. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis. Biochem Biophys Res Commun 2006, 343:1072-8. 10.1016/j.bbrc.2006.03.087, 16579972.
27. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 2000, 287:1253-8. 10.1126/science.287.5456.1253, 10678830.
28. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992, 16:1227-35.
29. Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C, Clergue F, Poupon R, Barbu V, Rosmorduc O. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 2005, 41:307-14. 10.1002/hep.20538, 15660382.
30. Kuriyama S, Yokoyama F, Inoue H, Takano J, Ogawa M, Kita Y, Yoshiji H, Deguchi A, Kimura Y, Himoto T, Yoneyama H, Kurokohchi K, Masaki T, Uchida N, Watanabe S. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model. Int J Mol Med 2007, 19:317-24.
31. El-Bassiouni A, Nosseir M, Zoheiry M, El-Ahwany E, Ghali A, El-Bassiouni N. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. Apmis 2006, 114:420-7. 10.1111/j.1600-0463.2006.apm_323.x, 16856963.
32. Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. Faseb J 1995, 9:1527-36.
33. Nagano K, Umeda Y, Saito M, Nishizawa T, Ikawa N, Arito H, Yamamoto S, Fukushima S. Thirteen-week inhalation toxicity of carbon tetrachloride in rats and mice. J Occup Health 2007, 49:249-59. 10.1539/joh.49.249, 17690517.
34. Desmouliere A. Hepatic stellate cells: the only cells involved in liver fibrogenesis? A dogma challenged. Gastroenterology 2007, 132:2059-62. 10.1053/j.gastro.2007.03.075, 17484899.
35. Noguchi S, Ohba Y, Oka T. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice. J Endocrinol 1991, 128:425-31. 10.1677/joe.0.1280425, 2013747.
36. Jones DE, Tran-Patterson R, Cui DM, Davin D, Estell KP, Miller DM. Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration. Am J Physiol 1995, 268:G872-8.
37. Daveau M, Scotte M, Francois A, Coulouarn C, Ros G, Tallet Y, Hiron M, Hellot MF, Salier JP. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Mol Carcinog 2003, 36:130-41. 10.1002/mc.10103, 12619035.
38. Perugorria MJ, Latasa MU, Nicou A, Cartagena-Lirola H, Castillo J, Goñi S, Vespasiani-Gentilucci U, Zagami MG, Lotersztajn S, Prieto J, Berasain C, Avila MA. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology 2008, 48:1251-61. 10.1002/hep.22437, 18634036.
39. Tsuchiya A, Kamimura H, Takamura M, Yamagiwa S, Matsuda Y, Sato Y, Nomoto M, Ichida T, Aoyagi Y. Clinicopathological analysis of CD133 and NCAM human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas. Hepatol Res 2009, 39:1080-90. 10.1111/j.1872-034X.2009.00559.x, 19619253.
40. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000, 97:14720-5. 10.1073/pnas.97.26.14720, 18985, 11121071.
41. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-56. 10.1053/j.gastro.2007.04.025, 17570225.
42. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D, Yang S, Zheng S, Gu J. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007, 120:1444-50. 10.1002/ijc.22476, 17205516.